Clinical pharmacology profile of boceprevir, a hepatitis C virus NS3 protease inhibitor: focus on drug-drug interactions

Clinical Pharmacokinetics
Sauzanne KhaliliehJoan R Butterton

Abstract

Boceprevir is a potent, orally administered ketoamide inhibitor that targets the active site of the hepatitis C virus (HCV) non-structural (NS) 3 protease. The addition of boceprevir to peginterferon plus ribavirin resulted in higher rates of sustained virologic response (SVR) than for peginterferon plus ribavirin alone in phase III studies in both previously treated and untreated patients with HCV infection. Because boceprevir is metabolized by metabolic routes common to many other drugs, and is an inhibitor of cytochrome P450 (CYP) 3A4/5, there is a high potential for drug-drug interactions when boceprevir is administered with other therapies, particularly when treating patients with chronic HCV infection who are often receiving other medications concomitantly. Boceprevir is no longer widely used in the US or EU due to the introduction of second-generation treatments for HCV infection. However, in many other geographic regions, first-generation protease inhibitors such as boceprevir continue to form an important treatment option for patients with HCV infection. This review summarizes the interactions between boceprevir and other therapeutic agents commonly used in this patient population, indicating dose adjustment requiremen...Continue Reading

References

Aug 1, 1990·Clinical Pharmacokinetics·B M Frey, F J Frey
Dec 1, 1995·Clinical Pharmacokinetics·R VenkataramananT Starzl
Feb 25, 2000·Therapeutic Drug Monitoring·H L Gallant-HaidnerR W Yatscoff
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H K MongaB Yoffe
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C S GrahamM J Koziel
May 31, 2002·Clinical Pharmacokinetics·David Williams, John Feely
May 10, 2003·Drug and Alcohol Dependence·C Nora Chiang, Richard L Hawks
Oct 9, 2003·Clinical Pharmacokinetics·Hans Lennernäs
Jul 30, 2004·The New England Journal of Medicine·Raymond T ChungUNKNOWN AIDS Clinical Trials Group A5071 Study Team
Dec 16, 2004·JAMA : the Journal of the American Medical Association·Fabrice CarratUNKNOWN ANRS HCO2 RIBAVIC Study Team
Jun 22, 2005·Clinical Pharmacokinetics·Alexander Elkader, Beth Sproule
Mar 22, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Tuomas KorhonenOlavi Pelkonen
Dec 3, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anima GhosalKevin B Alton
Apr 1, 2011·The New England Journal of Medicine·Fred PoordadUNKNOWN SPRINT-2 Investigators
Apr 1, 2011·The New England Journal of Medicine·Bruce R BaconUNKNOWN HCV RESPOND-2 Investigators
Apr 27, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Russell H Wiesner
May 12, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ellen HulskotteJoan Butterton
Jul 18, 2012·Clinical Pharmacokinetics·Michelle TreitelEric A Hughes
Sep 25, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Clara T M M de KanterDavid M Burger
Oct 19, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kyle P HammondJennifer J Kiser
Nov 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ellen G J HulskotteJoan R Butterton
Jan 8, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiaoyan ChuThomayant Prueksaritanont
Feb 15, 2013·The Journal of Infectious Diseases·Mark S Sulkowski
May 15, 2013·Therapeutic Drug Monitoring·Michael J DoltonAndrew J McLachlan
Dec 18, 2013·Journal of Hepatology·UNKNOWN European Association for Study of Liver
Dec 19, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Manoli VourvahisJayvant Heera
Mar 13, 2014·The Journal of Antimicrobial Chemotherapy·Akil JacksonMarta Boffito
May 20, 2014·British Journal of Clinical Pharmacology·Mark JohnsonStephen Piscitelli

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

The New England Journal of Medicine
Bruce R BaconHCV RESPOND-2 Investigators
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Steven L FlammFred Poordad
Expert Review of Anti-infective Therapy
Paul M TremblingGeoffrey Dusheiko
© 2021 Meta ULC. All rights reserved